Oh, Canada: Exopharm acquire Tryp Therapeutics
In a move known as a reverse merger, Exopharm Ltd have acquired Canadian biotech company Tryp Therapeutics, who will occupy Exopharm’s place on the ASX.
In a move known as a reverse merger, Exopharm Ltd have acquired Canadian biotech company Tryp Therapeutics, who will occupy Exopharm’s place on the ASX.
In this article.. The biotechnology industry is constantly evolving, with new companies emerging and established players making advancements every day. As we move through 2024, It’s important to recognise which companies are poised to make a significant impact. Currently, the market is leaning optimistically due to the high number of acquisitions into bopharma companies performed …